SiVEC Biotechnologies Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.3M

  • Investors
  • 8

SiVEC Biotechnologies General Information

Description

Developer of a live biotherapeutic delivery platform designed to advance nucleic acid and gene therapies into clinical trials. The company's delivery system uses genetically engineered bacteria as shuttle vehicles for safe, tissue-targeted delivery of therapeutics, including small interfering ribonucleic acid, micro ribonucleic acids, clustered regularly interspaced short palindromic repeats, and proteins, allowing the nucleic acid and gene editing therapies, enabling physicians with technology to address several therapeutic needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1505 West Mulberry Street
  • Fort Collins, CO 80521
  • United States
+1 (970)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1505 West Mulberry Street
  • Fort Collins, CO 80521
  • United States
+1 (970)

SiVEC Biotechnologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SiVEC Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Seed Round 17-Sep-2025 $3.3M Completed Pre-Clinical Trials
9. Accelerator/Incubator 01-Jan-2025 Completed Pre-Clinical Trials
8. Grant 18-May-2023 Completed Pre-Clinical Trials
7. Accelerator/Incubator 19-Apr-2022 Completed Pre-Clinical Trials
6. Grant 17-Sep-2021 Completed Pre-Clinical Trials
5. Grant 11-May-2020 Completed Pre-Clinical Trials
4. Grant 20-Aug-2018 Completed Pre-Clinical Trials
3. Grant 01-Jan-2018 Completed Pre-Clinical Trials
2. Grant 01-Mar-2016 $22K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2016 Completed Pre-Clinical Trials
To view SiVEC Biotechnologies’s complete valuation and funding history, request access »

SiVEC Biotechnologies Patents

SiVEC Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022286964-A1 Bacterial delivery of antibodies, antibody derivatives, and polypeptides to eukaryotic cells Pending 02-Jun-2021
CA-3220834-A1 Bacterial delivery of antibodies, antibody derivatives, and polypeptides to eukaryotic cells Pending 02-Jun-2021
WO-2022256519-A1 Bacterial delivery of antibodies, antibody derivatives, and polypeptides to eukaryotic cells Inactive 02-Jun-2021
AU-2021206307-A1 A microbial system for production and delivery of eukaryote-translatable mrna to eukarya Pending 11-Jan-2020
CA-3164395-A1 A microbial system for production and delivery of eukaryote-translatable mrna to eukarya Pending 11-Jan-2020 C12N15/70
To view SiVEC Biotechnologies’s complete patent history, request access »

SiVEC Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SiVEC Biotechnologies Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
William Taylor Nominees Venture Capital Minority
Springboard Enterprises Accelerator/Incubator
State of Colorado Government
California Life Sciences Accelerator/Incubator
National Institute for Allergy and Infectious Disease Government
You’re viewing 5 of 8 investors. Get the full list »

SiVEC Biotechnologies FAQs

  • When was SiVEC Biotechnologies founded?

    SiVEC Biotechnologies was founded in 2016.

  • Where is SiVEC Biotechnologies headquartered?

    SiVEC Biotechnologies is headquartered in Fort Collins, CO.

  • What is the size of SiVEC Biotechnologies?

    SiVEC Biotechnologies has 5 total employees.

  • What industry is SiVEC Biotechnologies in?

    SiVEC Biotechnologies’s primary industry is Drug Delivery.

  • Is SiVEC Biotechnologies a private or public company?

    SiVEC Biotechnologies is a Private company.

  • What is SiVEC Biotechnologies’s current revenue?

    The current revenue for SiVEC Biotechnologies is .

  • How much funding has SiVEC Biotechnologies raised over time?

    SiVEC Biotechnologies has raised $3.3M.

  • Who are SiVEC Biotechnologies’s investors?

    William Taylor Nominees, Springboard Enterprises, State of Colorado, California Life Sciences, and National Institute for Allergy and Infectious Disease are 5 of 8 investors who have invested in SiVEC Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process